Skip to main content
. Author manuscript; available in PMC: 2019 Jul 1.
Published in final edited form as: J Clin Lipidol. 2018 Apr 6;12(4):1047–1060. doi: 10.1016/j.jacl.2018.03.091

Figure 1.

Figure 1

Lipid mediator levels were assessed following solid phase extraction by liquid chromatography tandem mass spectrometry–based (LC-MS-MS–based) metabololipidomics (see Methods for details). (A) MS/MS spectra utilized for identification and prominent diagnostic ions listed in inset. Refer to Table I for patient demographics and Table II for quantification of bioactive lipid mediators. (B) Representative multiple reaction monitoring (MRM) traces for the identified lipid mediators in human psoriasis and healthy skin donors.